MENU
+Compare
TAK
Stock ticker: NYSE
AS OF
Sep 5 closing price
Price
$15.40
Change
+$0.11 (+0.72%)
Capitalization
48.8B

TAK Takeda Pharmaceutical Company Limited Forecast, Technical & Fundamental Analysis

Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4... Show more

TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TAK with price predictions
Sep 05, 2025

TAK in upward trend: 10-day moving average moved above 50-day moving average on August 20, 2025

The 10-day moving average for TAK crossed bullishly above the 50-day moving average on August 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where TAK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 05, 2025. You may want to consider a long position or call options on TAK as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for TAK just turned positive on August 07, 2025. Looking at past instances where TAK's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

TAK moved above its 50-day moving average on August 14, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TAK advanced for three days, in of 301 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 225 cases where TAK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TAK moved out of overbought territory on August 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TAK broke above its upper Bollinger Band on August 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.048) is normal, around the industry mean (16.681). P/E Ratio (53.301) is within average values for comparable stocks, (74.219). Projected Growth (PEG Ratio) (0.446) is also within normal values, averaging (1.902). Dividend Yield (0.043) settles around the average of (0.031) among similar stocks. P/S Ratio (1.633) is also within normal values, averaging (42.934).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TAK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TAK is expected to report earnings to fall 99.90% to 14 cents per share on October 30

Takeda Pharmaceutical Company Limited TAK Stock Earnings Reports
Q3'25
Est.
$0.15
Q2'25
Beat
by $150.82
Q1'25
Missed
by $0.06
Q4'24
Missed
by $0.05
Q3'24
Beat
by $0.07
The last earnings report on July 30 showed earnings per share of $151.00, beating the estimate of 17 cents. With 3.33M shares outstanding, the current market capitalization sits at 48.80B.
A.I.Advisor
published Dividends

TAK paid dividends on July 08, 2024

Takeda Pharmaceutical Company Limited TAK Stock Dividends
А dividend of $0.29 per share was paid with a record date of July 08, 2024, and an ex-dividend date of March 27, 2024. Read more...
A.I. Advisor
published General Information

General Information

a pharmaceutical products manufacturer

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1-1, Nihonbashi-Honcho 2-Chome
Phone
+81 332782306
Employees
49095
Web
https://www.takeda.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RMMZ14.690.24
+1.64%
RiverNorth Managed Duration Municipal Income Fund II
GSIE40.780.15
+0.37%
Goldman Sachs ActiveBeta® Intl Eq ETF
CAOS89.610.15
+0.17%
Alpha Architect Tail Risk ETF
INTW22.07-0.19
-0.85%
GraniteShares 2x Long INTC Daily ETF
SRS46.65-0.88
-1.86%
ProShares UltraShort Real Estate

TAK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+0.72%
HLN - TAK
42%
Loosely correlated
-0.41%
SGIOY - TAK
41%
Loosely correlated
+2.98%
ESAIY - TAK
35%
Loosely correlated
+2.66%
BNXTF - TAK
32%
Poorly correlated
+2.55%
ZTS - TAK
29%
Poorly correlated
+0.08%
More

Groups containing TAK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+0.72%
Pharmaceuticals: Generic
industry (222 stocks)
-0%
Poorly correlated
+2.50%